CD44 siRNA-encapsulated PNPs successfully silenced the expression of CD44 protein in CD34+ AML cells, demonstrating that HSPCs can be manipulated using PNPs (Gul-Uludağ et al., 2014). This evidence concerns the gene CD44 and acute myeloid leukemia.